𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Pneumocystis jirovecipneumonia in a patient with rheumatoid arthritis as a complication of treatment with infliximab, anti-tumor necrosis factor α neutralizing antibody

✍ Scribed by Shunsuke Mori; Fumiya Imamura; Chikage Kiyofuji; Kanako Ito; Yukinori Koga; Izumi Honda; Mineharu Sugimoto

Publisher
Springer
Year
2006
Tongue
English
Weight
350 KB
Volume
16
Category
Article
ISSN
1439-7595

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Listeria monocytogenes infection as a co
Listeria monocytogenes infection as a complication of treatment with tumor necrosis factor α–neutralizing agents
✍ Nancy R. Slifman; Sharon K. Gershon; Jong-Hoon Lee; Evelyne T. Edwards; M. Miles 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB 👁 1 views

## Abstract ## Objective Tumor necrosis factor α (TNFα) has been implicated in the pathogenesis of certain inflammatory diseases. Two TNFα‐neutralizing agents are licensed in the US. Infliximab is licensed for the treatment of Crohn's disease (CD) and, when used with methotrexate, for the treatmen

Active but transient improvement of endo
Active but transient improvement of endothelial function in rheumatoid arthritis patients undergoing long-term treatment with anti-tumor necrosis factor α antibody
✍ Gonzalez-Juanatey, Carlos ;Testa, Ana ;Garcia-Castelo, Alberto ;Garcia-Porrua, C 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 66 KB 👁 2 views

## Abstract ## Objective Cardiovascular disease is the major cause of excessive mortality in rheumatoid arthritis (RA). Atherosclerosis and RA share similar inflammatory mechanisms that include involvement of tumor necrosis factor α (TNFα). Anti‐TNFα antibody improved endothelial function in RA pa